Titlebook: Botulinum Toxin Treatment of Pain Disorders; Bahman Jabbari Book 20151st edition Springer Science+Business Media New York 2015 Analgesic.B

壯麗的去

Neuropathic Pain (NP), conventional treatment of common categories of neuropathic pain and reviews the literature on botulinum neurotoxin (BoNT) efficacy in neuropathic pain. The level of efficacy for BoNT treatment in each category is defined according to the published guidelines of the American Academy of Neurology. Th

準(zhǔn)則

Migraine and Other Primary Headaches,pe headaches are common and, in chronic form, are major causes of disability. Prospective double-blind and placebo-controlled studies have confirmed the efficacy of onabotulinumtoxinA (onaA) in chronic migraine (class A evidence). Follow-up of patients in PREEMPT studies with five cycles of onaA inj

ARC

ANT

eustachian-tube

Botulinum Toxin Treatment of Piriformis Syndrome,rby sciatic nerve (or one of its major divisions) by a tense and overactive piriformis muscle. Current treatments consist of stretching exercises, oral medications, and anesthetic or steroid injections; these approaches are only partially effective. Two double-blind, placebo-controlled studies have

carotenoids

Botulinum Toxin Treatment of Myofascial Pain Syndrome and Fibromyalgia,nt of myofascial pain syndrome is partially successful with conventional analgesics, but a large number of patients remain unsatisfied..Botulinum neurotoxins (BoNTs) can relieve myofascial pain by blocking the release of acetylcholine and pain mediators (substance P, glutamate, calcitonin gene-relat

不感興趣

monopoly

可憎

Botulinum Neurotoxins for Relief of Pain Associated with Spasticity,atment, although effective, is confounded by undesirable side effects and short duration of response. Botulinum neurotoxins (BoNTs) have been approved by FDA for treatment of spasticity. The role of BoNT therapy in spasticity-related pain is less established. In this chapter, the literature from dou

defeatist

Treatment of Dystonic Pain with Botulinum Neurotoxins,onias, namely, cervical dystonia, focal dystonia associated with neurodegenerative disorders, and post-traumatic dystonia. The literature on the efficacy of botulinum toxins for these three forms of dystonic pain is reviewed. Fourteen blinded and placebo-controlled clinical trials assessed pain at b